As a longstanding leader in the scientific advancement of vaccines and immune therapies, AstraZeneca continues to drive education and awareness of the burden of influenza on public health and the importance of vaccination. Despite national coverage of past flu season severity, there remains a lack of understanding of the protection that immunization helps provide along with the potential impact that innovative vaccines can deliver for at-risk communities. Read how AstraZeneca expands innovative, accessible vaccines and immune therapies to help protect patients and reduce disease burden.